(NASDAQ: COO) Cooper Companies's forecast annual revenue growth rate of 4.77% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 8.88%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.36%.
Cooper Companies's revenue in 2025 is $3,988,200,000.On average, 7 Wall Street analysts forecast COO's revenue for 2025 to be $821,468,993,232, with the lowest COO revenue forecast at $820,048,264,691, and the highest COO revenue forecast at $822,889,322,748. On average, 7 Wall Street analysts forecast COO's revenue for 2026 to be $874,160,046,026, with the lowest COO revenue forecast at $866,636,429,500, and the highest COO revenue forecast at $879,989,801,393.
In 2027, COO is forecast to generate $924,209,154,242 in revenue, with the lowest revenue forecast at $916,241,223,370 and the highest revenue forecast at $934,596,373,738.